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Summary.-We have compared the actions of ADM and mAMSA in Chinese hamster
V79 cells in vitro, using cell survival and sister-chromatid exchange as end-points.
Equimolar concentrations of ADM and mAMSA show similar toxicities to exponen-
tially growing cells, and both drugs are less effective in killing chronically hypoxic
and plateau-phase cells. Cytotoxicity to thermotolerant cells (41°C for 16 h previously)
shows little difference from that for exponential cells. Pre-treating cells with
misonidazole under hypoxic conditions reduces thetoxicityofbothADM and mAMSA.
In addition, an ADM-resistant Chinese hamster cell line, 77A-177, was cross-
resistant to mAMSA. Finally, low equimolar sub-toxic doses of both drugs were
found to cause similar increases in the levels of sister-chromatid exchanges in V79
cells. These results reveal no major difference in activity between ADM and mAMSA
in vitro.
ADRIAMYCIN (ADM) is thought to be
cytotoxic due to its ability to intercalate
between adjacent base pairs in DNA
(Zunino et al., 1972). It has been used
clinically since 1969 and has been shown
to be effective in a variety of human tu-
mours. However, the efficacy of this drug
is limited by its cardiotoxicity (Carter,
1975). Another drug which is thought to
act by intercalation of DNA is 4'-1(9-
acridinyl)-amino]methanesulphon -m -ani-
sidide (mAMSA, NSC 249992) (Gormley
et al., 1978). This acridine derivative,
which was one of a series synthesized by
Atwell et al. (1972), has recently completed
Phase I and II clinical studies (Legha
et al., 1978, 1979; Schneider et al., 1979,
1980) and is now undergoing prospective
randomized trials. Cell-kinetic studies in
vitro have shown ADM and mAMSA to
have similar effects, which has led to the
suggestion that mAMSA may be an alter-
native to ADM in the clinic (Tobey et al.,
1978).
The present work was undertaken to
compare directly the toxicity ofADM and
mAMSA to mammalian cells in vitro.
This was done using V79 cells with differ-
ing culture histories and a cell line with
induced resistance to ADM. The response
of cells to ADM and mAMSA after treat-
ment withmisonidazole was alsoexamined,
since in previous studies where misonida-
zole has been used in combination with
alkylating agents a synergisticcytotoxicity
has been seen (Rose et al., 1980; Stratford
et al., 1980). Finally, sister-chromatid
exchanges (SCEs) were used to indicate
DNA damage caused by each drug.
MATERIALS AND METHODS
Cells.-Chinese hamster V79-379A cells
wvere used in most of these experiments. Cells
were routinely grown at 37°C in 250ml conical
flasks in Eagle's minimal essential medium
(MEM) modified for suspension cultures
(Flow Laboratories Ltd) and supplemented
with 7-5o foetal calf serum (FCS) (Gibco-
Biocult Ltd). Cells were maintained in log-
phase growth at concentrations varying
between 105 and 106 cells per ml. A doublingADil I'S mAMlSA IN VITRO7
time of 10-12 h required cells to be diluted
daily. V79-379A cells were also grown in
monolayer culture in MEM plus 15% FCS,
and passaged twice weekly. All medium con-
taining cells wvas buffered with bicarbonate
to pH 7-4. For most experiments cells were
harvested from asynchronous exponentially
growing cultures.
Some experiments -were done with cells
with a history of chronic hypoxia, plateau-
phase cells, cells cultured at pH 6-8 or thermo-
tolerant cells. Cells w-ith a history of chronic
hypoxia were prepared by taking log-phase
cells and holding them for 16 h under
anaerobic conditions (Smith et al., 1980;
Rajaratnam et al., 1981). Plateau-phase cells
were taken from unfed suspension cultures
which became density inhibited at a cell con-
centration of 1 2-1-6 x 106 cells/ml. Under
these conditions, the pH of the culture
medium had been reduced to around 6-9.
Other experiments involving reduced pH
were done with exponentially growing cells
which had been cultured in medium at pH 6-8
for 16 h before drug treatment. Thermo-
tolerant cells were prepared by maintaining
log-phase cells at 41°C (pH 7 4) for 16 h
(Stratford et al., 1981b). V79 cells cultured
under conditions of either reduced pH or
41TC are still capable of progression, with
doubling times about 16 and 20 h respect-
ively.
The culture conditions described above
were not inimical to our V79 cells, and all
these cell populations had plating efficiencies
> 9000 before treatment with cytotoxic drugs.
An ADM-resistant Chinese hamster cell
line (77A-177, Belli & Harris, 1979; Belli,
1979) was sometimes also studied. These cells
had originally been exposed to 0-1~tM ADM
for 77 weeks, followed by a further 177 weeks
growth in drug-free medium, during which
time they retained their resistance to ADM.
In our experiments they w-ere maintained in
exponential phase in monolayer culture in
MEM plus 15% FCS.
Cytotoxicity studies-Cells at 5 x 105/ml
were transferred to plastic universal con-
tainers with the required amount of drug to
give a final volume of 10 ml. The containers
were placed in a shaking water bath at 37°C
in air. After 1 h the cells wrere removed,
washed by centrifugation and resuspension,
counted, diluted and plated in MEM plus
15% FCS. They were then incubated for 7
days at 37°C before staining in methylene
blue and scoring for colony formatioin. All
colonies visible at x 2 magnification ( 50
cells or more) were counted.
Some experiments involved pre-treatment
with misonidazole (Stratford et al., 1980).
Exponentially growing cells were exposed to
5mM misonidazole at 37°C for 2 h under
hypoxic conditions, before treatment in air
with mAMSA or ADM.
The 77A-177 (ADM-resistant) cells were
treated with ADM or mAMSA as follows.
Cells w%vere harvested from a monolayer by
washing with 0 02% EDTA and 0)08% tryp-
sin, counted, diluted and plated on to 6cm
plastic Petri dishes in a total volume of 2 ml
MEM plus 15O% FCS. The cells were left to
attach for 2-1 h, the medium aspirated from
the dishes and replaced mith 2 ml fresh
medium containing either mAMSA or ADM.
Dishes were incubated for 1 h at 37°C, aspir-
ated, replenished with 2 ml fresh growth
medium and incubated for 7 days. As a con-
trol, parallel experiments were conducted in
an identical fa.shion using V79-379A cells.
SCE experiments.-Asynchronous, expo-
nential V79-379A monolayer cultures were
grown in the presence of 10tM 5-bromo-
deoxyuridine (BrdU, Sigma) for 18 h in dark-
ness (Ben-Hur & Elkind, 1972). During the
first hour the cultures w%Nere treated with
ADM or mAMSA. Colcemid (CIBA), at a final
concentration of 10-6M Mwas added for the
final 2 h of the BrdU exposure. The cells
wNere harvested bytrypsinization, resuspended
in 0-075m KCI for 15 min and fixed with
methanol:glacial acetic acid (3:1). Air-dried
slides were stained in 0 4 mg/ml Hoechst
33258 for 4 h, rinsed in distilled water and
mounted in 0-16M disodium orthophosphate
and 0-04M trisodium citrate (pH 8-8). The
slides were exposed for 45 min to fluorescent
light from a Philips CS200W-4 mercury lamp
mounted on a Reichert "Polyvar" micro-
scope and filtered with a Reichert "V2"
excitation filter. Finally, the slides were
rinsed and restained in 40o Giemsa for 5 min.
Compounds. mAMSA, supplied by the
late Dr B. F. Cain (Auckland Division, Cancer
Society of New Zealand) was made up in dis-
tilled water immediately before use. Concen-
trations were measured spectrophotometric-
ally at 433 nm. Adriamycin (ADM) available
in 10mg sterile vials (Montedison Pharma-
ceuticals Ltd) was reconstituted in 5 ml sterile
distilled w-ater and diluted with PBS.
Misonidazole wNas supplied by Dr Carey
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Fic. 1.-Effect of a lb exposure of ADMI or mAl\ISA on thie suir\vival of exponentially growing V79-
379A cells in air at 37°C. Points represent the average of 5 experiments and error bars the spread
of the data.
Smithen of Roche Products Ltd, Welwyn
Garden City, Herts, and was made up in
MEM plus 7*5%0 FCS on the day required.
RESULTS
ADM and mAMSA show dose-dependent
cytotoxicity to exponentially growing,
aerobic V79-379A cells at 37°C (Fig. 1).
The survival curve for mAMSA shows
that for each increment in drug dose the
corresponding decrease in survival is
smaller. The shape of the survival curve
for ADM is basically the same as for
mAMSA, except that at low doses there
is an apparent shoulder. Similar results for
exponentially growing V79 cells exposed
to ADM or mAMSA have been obtained
by Belli & Harris (1979) and Wilson et al.
(1981).
Figs 2 and 3 show the cytotoxicity of
ADM and mAMSA to plateau-phase cells,
cells rendered chronically hypoxic,thermo-
tolerant cells and cells grown at pH 6-8.
When compared to data for exponentially
growing cells at pH 7-4 (Fig. 1) it is evident
that, for treatment with either drug:
1. Plateau-phase cells and cells rendered
chronically hypoxic before drug treat-
ment in air are resistant to drug action;
2. After prolonged exposure of exponen-
tially growing cells to reduced medium
pH, the cytotoxicity is reduced, but
this is not sufficient to account wholly
for the decreased sensitivity of plateau-
phase cells; and
3. There is no change in thedrugsensitivity
of thermotolerant cells.
Fig. 4 shows results comparing the effect
of the two drugs on the ADM-resistant
77A-177 cells. It is clear that this cell line
is cross-resistant to mAMSA.
We have carried out experiments to
ascertain whether misonidazole poten-
tiates the effect of the intercalating agents
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FIG. 2.-Effect of lh exposure to ADM in air at 370C on the response of plateau-phase cells, cells
rendered chronically hypoxic, thermotolerant cells, and cells grown at pH 6-8. Points represent the
average of 3 experiments and error bars the spread of the data. Points alone show the mean of two
experiments.
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ADM and mAMSA in the same way as
with alkylating agents (Rose et al., 1980;
Stratford et al., 1980). Fig. 5 shows that
pretreatment with misonidazole in N2
Plateau phase cells
162
c
0
A;.
pH 68
mAMSA concentration/p M
(which alone reduces survival to around
0.6) protects against the subsequent expo-
sure to ADM or mAMSA. For 1OpM
ADM the survival is increased 10-fold,
e oPreviusly hypoxt cells
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FIG. 3.-Effect of lh exposure to mAMSA in air at 37°C on the response of plateau-phase cells,
cells rendered chronically hypoxic, thermotolerant cells, and cells grown at pH 6-8. Points represent
the average of 3 experiments and error bars indicate the spread of the data.
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FIG. 4.-Survival curves for V79-379A (0) and 77A-177 cells (O) exposed to ADM or mANISA for
1 h. in air at 37 C. Points represent the mean of 2 experiments.
whereas for 1OtkM mAMSA survival is
increased 100-fold. The cytotoxicity of
ADM or mAMSA was unaffected, whether
the pretreatment was with misonidazole
in air for 2 h or with N2 alone for 2 h
(data not shown).
A comparison of the DNA-damaging
effects of ADM and mAMSA was carried
out using SCE as an end-point. The fre-
quencies of SCE as a function of subtoxic
doses of the drugs are summarized in the
Table, and dose-response curves are illus-
trated in Fig. 6. Fig. 7 shows a chromo-
some spread for a cell treated with ]0,M
BrdU for 18 h; SCE were scored by count-
ing the exchange sites (arrows in Fig. 7).
Fig 8 and 9 show the distribution of
SCE per cell within the dividing popula-
tion after treatment with either ADM or
mAMSA. There is a dose-dependent in-
crease in the incidence of SCE after
treatment with either drug, though at
higher concentrations ADM appears to be
slightly more effective.
SCE experiments involved cells being
treated with 10uM BrdU for 18 h. In
drug-free controls it was found that this
treatment alone reduced the surviving
fraction to -0-8. However, little further
reduction in the surviving fraction is seen
when a lh exposure to 041 and 0 2Mm
of either drug is given in combination
with BrdU treatment.
DISCUSSION
In this study we have set out to compare
in vitro the cytotoxic and DNA-damaging
effects of two intercalating agents, ADM
and mAMSA. Both drugs produce survival
curves of similar shape for exponentially
growing cells. It is not clear from our data
whether the shape of the survival curves
is duetoheterogeneity ofdrug sensitivities.
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ADM concentration/pM mAMSA concentration/PM
FiG. 5.-Survival curves of V79-379A cells treated with 5mM misonidazole for 2 h under hypoxic conditions before a lh drugexposure to ADM ormAMSA, in airat 370C. Points represent the average of 3 experiments and error bars the spread of the data. Dashed lines are the survival curves in the same experiment for cells un-pretreated.
TABLE.-Frequency of SCE in ADM- and
mAMSA-treated cells. 100 well-spread
metaphases with 22 chromosomes were
scored for each drug concentration
Drug dose
(PM)
Control
mAMSA
ADM {
005
0*10
0-15
0-20
0*05
0*10
0*15
0-20
SCE
metaphase
+s.e.
6-7+003
10-7+0-4
15-6+0 7
18-0+ 0-6
22-8+0-9
10-7+0-4
16-6+0-5
22-7+007
27-3+0-9
Range
1-12
2-22
1-33
6-34
6-44
3-20
6-27
10-46
12-56
However, it has been suggested by others
(Belli & Piro, 1977) that at high concen-
trations ADM may saturate target binding
sites. This model is consistent with the
shapes of the dose-response curves for
ADM, and a similar mechanism may
apply to mAMSA.
There is considerable difference between
the drug sensitivities ofplateau-phase and
log-phase cells. For 1O,UM ADM, surviving
fractions are 0-4 x 10-4 and 0-25 for
exponentially growing and plateau-phase
cells respectively, and for a similar con-
centration of mAMSA the surviving frac-
tion of these cell populations are 0-2 x
10-3 and 0-2 x 10-1. This indicates that
the differential in sensitivity between
cycling and non-cycling cells may be
somewhat greater for ADM. It has been
shown previously that there is little
difference in the sensitivity of cycling and
non-cycling cells towards mAMSA when
iso-leucine starvation is used to produce
non-cycling cultures (Tobey et al., 1978).
Further, Tobey et al. (1976) showed that
the differential toxicity of ADM for
cycling vs non-cycling cells (produced by
iso-leucine starvation) is much less than
that reported here and in the work of
others (Barranco et al., 1974; Twentyman,
1976). Non-cycling cells produced by
Tobey et al. (1976, 1978) compared with
plateau-phase cells induced as described
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FIG. 6. The relationship between drug dose
and SCE frequency. Points represent the
mean of 100 metaphases scored from at
least 3 separate experiments and error bars
indicate s.e.
in this work may represent different
growth-arrested states. Cells harvested
from exponentially growing cultures and
held for 16 h under hypoxic conditions
experience growth arrest, and become
resistant to ADM (Smith et al., 1980).
These cells are also more resistant than
exponentially growing cells to mAMSA.
Cells held at 41°C for long enough to
modify their response to heat damage
(Stratford et al., 1981a) or the cytotoxic
action of some drugs (Stratford et al.,
1981b) continue cycling, and this in turn
is reflected in these cells having similar
sensitivities to ADM and mAMSA when
compared to exponentially growing cells
held constantly at 37°C. Taken together
these results are consistent with the pro-
posal that the growth status of cells in
vitro will be an important determinant
of sensitivity to ADM or mAMSA.
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Cells held at pH 6-8 for 16 h before drug
treatment continue cycling. However, the
cells at this pH are slightly more resistant
to bothADM and mAMSA when compared
to exponentially growing cells held at pH
7-4. Both mAMSA and ADM are weak
bases, with pKa values of 7-3 (Wilson
et al., 1981) and 8-2 (Skovsgaard, 1977)
respectively. Changes in drug uptake with
associated changes in toxicity have been
reported as a function of pH for cells
exposed to ADM (Skovsgaard, 1977).
Further, the cytotoxicity of mAMSA has
been reported to be maximal at pH 7-2
(Wilson et al., 1981). The pH range 6-8-
7'4 spans that in which tumour cells may
be found in vivo and it may be important
that at these values of pH the cytotoxic
actions of ADM and mAMSA are similar.
The basic similarities between the cyto-
toxic effects of ADM and mAMSA are
further demonstrated by the fact that a
cell line with induced resistance to ADM
shows cross-resistance to mAMSA. This
cell line has also been shown to be cross-
resistant to Actinomycin D (Belli &
Harris, 1979) which has been attributed
to genetically controlled membrane
changes resulting in decreased drug
uptake (Harris et al., 1979).
Cells given 5mM misonidazole for 2 h
in N2 before exposure to either ADM or
mAMSA become resistant to the cytotoxic
actions of both intercalating agents.
There is no such effect if cells are pre-
treated with 5mM misonidazole in air
for 2 h, nor when cells are given N2 for
2 h with no misonidazole. The exposure
to misonidazole in N2 reduces survival to
0-6; it is known that misonidazole shows
cell-cycle specificity, inits cytotoxic action
with cells in early S being most sensitive
and late S/G2 cells most resistant (Whit-
more & Gulyas, 1980; Stratford, 1980).
The published data on the age responses
of cells to ADM and mAMSA have yielded
differing results (Kim & Kim, 1972;
Barranco, 1975; Bhuyan et al., 1980;
Deaven et al., 1978; Roberts & Millar,
1980). However, preliminary work with
synchronizedV79 cells(West,unpublished)
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FIG. 7.--Chromosomes of V79-379A cells labelled with 10 ,Im BrdU slowing "lharlequinized" sister
chromaticls. SCEs are scored by counting the sites of each exclhange (arrows).
has indicated that both intercalating
agents may be most effective in early S.
Therefore, our results may indicate that
the observed "resistance" to ADM and
mAMSA is due to a cell-cycle redistribu-
tion caused by misonidazole pretreatment
in N2. The somewhat greater resistance
to mAMSA than to ADM may be due to
subtle differences in age response between
these two drugs. An alternative explana-
tion for these results would be that the
exposure of cells to misonidazole in N2
alters the cells' membrane properties or
metabolic state. Such changes are known
when cells are given 5mm misonidazole
for 14 h in air, and these cells also become
more resistant to ADM (J. Belli, personal
communication). However, at present we
are not able to state categorically which of
these mechanisms is operating when cells
are given ADM or mAMSA immediately
after hypoxic exposure to 5mM misonida-
zole.
Previous studies have shown that ADM
and other intercalating agents can pro-
foundly increase the frequency of SCE in
CHO cells (Au et al., 1981; Galloway &
Wolff, 1979; Perry & Evans, 1975). Raj &
Heddle (1980) have demonstrated that, in
general, intercalating agents are efficient
inducers ofSCE, and the present work con-
firms these results for V79 cells exposed to
ADM.Concentrations ofADM andmAMSA
between 0 05 and 0-2 ttM have been used
to follow the induction of SCE. Although
these drug doses produce no significant
cytotoxicity as measured by the clono-
genic assay, we cannot, on the strength of
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FIG. 8. The effect of varying concentrations
of ADM on the induction of SCE in
V79-379A cells (Ih exposure in air at 37°C).
these data alone, deduce whether this
end-point may be related to SCE induc-
tion. However, it is apparent that the
magnitude of SCE formation by each drug
is similar (e.g. at 0u1 4uM the SCE per cell
is 15-6 + 0-7 and 16-6 + 0 5 for mAMSA
and ADM respectively, compared to only
6-7 + 0 3 for untreated controls). Less
SCE was found in cells exposed to 015/UM
or 0'2iLM mAMSA than in those treated
with the equivalent concentration ofADM
(Fig. 6). The data illustrated in Figs 8
and 9 show that at these drug levels there
is a wide distribution of the numbers of
SCE scored, with no well-defined mode,
after 0-2,UM mAMSA. This change in the
form of the distribution may result from
slight variation in cycle-stage sensitivity
to drug action, and therefore the difference
between ADM and mAMSA at this dose
level may not be significant. Further, the
16 20 4-a 2 0 44 4 52 '56
SCE per cell
FIG. 9. The effect of varying concentrations
of mAMSA on the induction of SCE in
V79-379A cells (lh exposure in air at
37°C).
proportion of non-differentially stained
mitoses (1st divisions) appeared higher
after treatment with 0 2,tM mAMSA than
after the corresponding dose of ADM,
suggesting that atthesedosesmAMSAmay
induce more mitotic delay than ADM.
Taking these qualifications into account,
it is nevertheless apparent that ADM and
mAMSA induceSCE atasimilarfrequency.
In conclusion, we have demonstrated
that the DNA damaging and cytotoxic
effects of ADM and mAMSA are broadly
similar, under a variety of test conditions
in vitro. We suggest, therefore, that
should any difference in effect be seen for
these drugs in vivo or indeed clinically,
this difference will have its origins in the
pharmacology of the two drugs, i.e. their
uptake, tumour penetration, metabolism
and excretion, rather than in inherent
differences in cell sensitivity.
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